| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |